Friday, September 30, 2022



Contact us 561.316.3330

US Patent Issued to REVIAN® Duel Band LED Light Therapy

The United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 10,265,258 – the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body.

“This is a groundbreaking approach to the therapeutic use of light,” said Dr. Nathan Stasko, co-inventor and Executive Chairman REVIAN Inc. “We set out to decode the spectrum of light and identify which wavelengths encourage cells, tissues and organs to repair themselves.”

The claims in this issued patent cover the use of specific wavelengths of LED light to stimulate the body’s cellular generation of nitric oxide as well as to release the body’s natural nitric oxide reserves. Nitric oxide has a remarkably diverse range of biological functions as it is involved in the proper function of virtually every organ in the human body, and its decline is linked to many degenerative diseases of aging.

“By stimulating the body’s internal mechanisms for the generation and release of nitric oxide, we are able to realize the therapeutic benefits of nitric oxide in the body without the challenges of pharmaceutical drug development,” continued Dr. Stasko.

The assembly of such an experienced team in both LED and medical discovery to address the needs of the body is unprecedented. The group of inventors listed on the patent represents the same fusion of life science and light science that their invention embodies. Among them, this group has over 500 patent filings and over 250 issued patents, the bulk of which can be attributed to Gerry Negley, co-inventor and arguably the foremost expert on the creation and delivery of LED light. He is inventor or co-inventor on about every major advancement in LED-based light. Now REVIAN, and its parent company KNOW Bio, are unleashing the power of LED technology to create optimum biological outcomes.

“The body’s natural capabilities to heal and regenerate itself can be unlocked using light,” said Gerry Negley. “With this technology, we are doing just that by using a proprietary combination of monochromatic LEDs.”

Medical LED systems are possible because of the decades of innovation in semiconductor materials that have now created the ability for light to be delivered in precise, narrow bands that lead to direct engagement of biological tissues. With power levels at or exceeding the output of lasers, higher efficiency LEDs enable devices that are durable, smaller, lightweight and far more comfortable and convenient for people to use.

REVIAN RED is the first product to employ the therapeutic advances enabled by combining LED technology and nitric oxide medical research. This advanced medical device is clinically proven to stop hair loss and grow new hair, providing a potentially life-changing treatment for men and women suffering from androgenetic alopecia.

“Our patented dual-band technology can give new hope to the estimated 50 million men and 30 million women suffering from androgenetic hair loss in the United States and to hundreds of millions more around the globe,” said Brian Johnson, President REVIAN Inc. “When you add a second wavelength and use LEDs to provide a whole new patient experience designed from the ground up to be comfortable, effective, safe and convenient—you have REVIAN RED, the most technologically advanced answer for these millions of sufferers.”

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

By using this website you agree to accept Medical Device News Magazine Privacy Policy